Astellas Pharma ADR (ALPMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2024 | 12-2023 | 09-2023 | 06-2023 | 12-2022 | |
| Sales | 3,027,994 | 0 | 0 | 2,737,427 | 0 |
| Cost of Goods | 583,270 | N/A | N/A | 503,313 | N/A |
| Gross Profit | 2,444,723 | N/A | N/A | 2,234,114 | N/A |
| Operating Expenses | 2,120,789 | 0 | 0 | 1,900,124 | 0 |
| Operating Income | 324,205 | N/A | N/A | 334,296 | N/A |
| Interest Expense | 28,768 | 0 | 0 | 19,856 | 0 |
| Other Income | 27,731 | 0 | 0 | 27,565 | 0 |
| Pre-tax Income | 323,168 | 0 | 0 | 342,005 | 0 |
| Income Tax | 82,509 | N/A | N/A | 100,163 | N/A |
| Net Income Continuous | 240,659 | N/A | N/A | 241,842 | N/A |
| Net Income | $240,659 | $N/A | $N/A | $241,842 | $N/A |
| EPS Basic Total Ops | 0.13 | N/A | N/A | 0.13 | N/A |
| EPS Basic Continuous Ops | 0.13 | N/A | N/A | 0.13 | N/A |
| EPS Diluted Total Ops | 0.13 | N/A | N/A | 0.13 | N/A |
| EPS Diluted Continuous Ops | 0.13 | N/A | N/A | 0.13 | N/A |
| EPS Diluted Before Non-Recurring Items | 0.24 | 0.12 | -0.01 | N/A | 0.27 |
| EBITDA(a) | $645,920 | $N/A | $N/A | $503,985 | $N/A |